Ovarian Cancer Treatment Landscape & Competitive Analysis, 2016 - Research and Markets - PowerPoint PPT Presentation

Loading...

PPT – Ovarian Cancer Treatment Landscape & Competitive Analysis, 2016 - Research and Markets PowerPoint presentation | free to download - id: 829370-MTA2O



Loading


The Adobe Flash plugin is needed to view this content

Get the plugin now

View by Category
About This Presentation
Title:

Ovarian Cancer Treatment Landscape & Competitive Analysis, 2016 - Research and Markets

Description:

Avail more information from Sample Brochure of report @ Ovarian Cancer which mainly describes the treatment of ovarian cancer at different stages. Ovarian cancer is the sudden growth of the cells in the ovary and is a type of cancer that affects females only. The cancer forms in tissues of the ovary when normal cells are affected. It can affect either one or both the ovaries. It is estimated that every year approximately 21,000 women in USA and 5,500 women in UK are diagnosed with ovarian cancer. Read Analysis @ – PowerPoint PPT presentation

Number of Views:15

less

Write a Comment
User Comments (0)
Transcript and Presenter's Notes

Title: Ovarian Cancer Treatment Landscape & Competitive Analysis, 2016 - Research and Markets


1
Ovarian Cancer - Treatment Landscape
Competitive Analysis, 2016
Published on 04 July, 2016 Number of pages
90 Single User Price 2450
MarketIntelReports, Ovarian Cancer - Treatment
Landscape Competitive Analysis, 2016, report
provides comprehensive insights about the
treatment landscape across this indication. This
report also provides the deep understanding of
the stages of the ovarian cancer, epidemiology,
risk factors, diagnosis etc.
Click Here To Check Complete Report
2
A key objective of the report is to establish the
understanding of the treatment landscape and
competitive analysis of the Ovarian Cancer which
mainly describes the treatment of ovarian cancer
at different stages. Ovarian cancer is the sudden
growth of the cells in the ovary and is a type of
cancer that affects females only. The cancer
forms in tissues of the ovary when normal cells
are affected. It can affect either one or both
the ovaries. It is estimated that every year
approximately 21,000 women in USA and 5,500 women
in UK are diagnosed with ovarian cancer. It is
the eighth most common cancer among women in USA
and fifth most common cancer among females in UK.
Avail more information from Sample Brochure of
report
3
This report provides the insights of the marketed
drugs for the Ovarian Cancer which includes the
Targeted Therapy and Chemotherapy. These days
companies are focusing on the Targeted Therapy
for cancer. Many big pharmaceuticals companies
are involved in ovarian cancer with their
preregistration products. Cediranib of
AstraZeneca and Paclitaxel of Oasmia
Pharmaceutical AB is ready to hit the market in
few coming years. All are in preregistration
stage. Along with the Targeted Therapy, this
report also provides the landscape of
Chemotherapy available for the Ovarian Cancer.
This report also covers the comparison of the
Targeted Therapy and Chemotherapy which provides
the insights for the marketed drugs. Analysis of
the marketed drugs provides the understanding of
cost of treatment, therapeutic class, patent
expiry and sales data of the drugs.
4
Recent report of MarketIntelReports covers the
treatment landscape which provides the treatment
options by different stages of the ovarian
cancer. Currently the treatment is divided into
the Targeted therapy and Chemotherapy. There are
two products under Targeted therapy and seven
products under Chemotherapy. Note This report
will be delivered to the client in 48 hours
  • Report Highlights
  • The new report, provides a Ovarian Cancer
    Treatment Landscape across the globe
  • The report provides profiles of the marketed drug
    which includes the product description, cost of
    treatment, development partner, patent expiry
    date, sales data etc.

5
  • Comparative analysis of marketed drugs by
    therapy, cost of treatment and Therapeutic Class.
  • Coverage of the Ovarian Cancer Phase III and
    Pre-registration Drugs Analysis by product type,
    molecule type, route of administration, Median
    Progression Free Survival
  • The report reviews key players involved in the
    therapeutics development for Ovarian Cancer and
    also provide market barriers, market drivers and
    opportunities
  • Provides Phase III products assessment by
    monotherapy and combination therapy products, and
    molecule type.

Make an Inquiry Before Buying
6
Ovarian Cancer - Treatment Landscape
Competitive Analysis, 2016
A detailed qualitative analysis of the factors
responsible for driving and restraining growth of
Ovarian Cancer - Treatment Landscape
Competitive Analysis, 2016 and future
opportunities are provided in the report.
Contact 1-302-261-5343 sales_at_marketintelreports.c
om www.marketintelreports.com
Click here to order a copy of Ovarian Cancer
Market Report
About PowerShow.com